2011-08-01T08:58:39-07:00 2010-09-30 990 2009-10-01 237413005 FAMILY HEALTH INTERNATIONAL FAMI 9195447040 PO BOX 13950 RESEARCH TRIANGLE PARK NC 277093950 HUBERT C GRAVES 9195447040 2011-08-15 2009 2016-02-24 21:20:13Z DR ALBERT J SIEMENS 2224 E NC HWY 54 DURHAM NC 27713 352032940 0 X FHI.ORG X 1973 NC TO IMPROVE LIVES IN LASTING WAYS IN THE U.S. AND AROUND THE WORLD 8 2 661 0 0 0 1519707 1376361 325885842 349151668 191201 259653 -37955 -96567 327558795 350691115 0 0 0 0 63639156 64745142 0 0 213157 261000545 284496505 324639701 349241647 2919094 1449468 80400692 78323925 61793570 58267335 18607122 20056590 FHI IS A GLOBAL DEVELOPMENT ORGANIZATION EMPLOYING MULTIDISCIPLINARY, EVIDENCE BASED APPROACHS TO ADDRESS THE HEALTH AND SOCIOECONOMIC CHALLENGES OF MILLIONS OF LIVES IN DISADVANTAGED COMMUNITIES THROUGHOUT THE WORLD. 0 0 256210827 0 281763801 SCIENCE & TECHNOLOGY RESEARCH GENERAL AND OTHER: FHIs PUBLIC HEALTH RESEARCH INNOVATIONS AND PROGRAM APPROACHES ADDRESS KEY DISEASES INCLUDING HIV/AIDS, MALARIA, TUBERCULOSIS, ROTAVIRUS, AND CARDIOVASCULAR DISEASE, BENEFITING MILLIONS ACROSS 54 COUNTRIES. THIS YEAR, FHI PROVIDED NEARLY 2.4 MILLION PEOPLE WITH HIV COUNSELING AND TESTING. ANTIRETROVIRAL THERAPY (ART) PROGRAMS NOW TREAT CLOSE TO 186,000 PEOPLE LIVING WITH HIV/AIDS, INCLUDING MORE THE 14,000 CHILDREN. ART IS DELIVERED IN THE CONTEXT OF COMPREHENSIVE PREVENTION AND CARE PROGRAMS THAT LINK CLIENTS TO OTHER NEEDED HEALTH, COUNSELING, INCOME GENERATION, EDUCATION, AND DEVELOPMENT SERVICES. (O NONE). 30142450 0 44582787 SCIENCE & TECHNOLOGY RESEARCH, GENERAL,OTHER: FHI CONDUCTS RESEARCH TO INCREASE THE RANGE OF AVAILABLE CONTRACEPTIVE CHOICES AND THE AVAILABILITY OF SAFE, EFFECTIVE, ACCEPTABLE, AND AFFORDABLE CONTRACEPTIVE METHODS AND REPRODUCTIVE HEALTH TECHNOLOGIES THROUGH HIGH QUALITY FAMILY PLANNING AND REPRODUCTIVE HEALTH SERVICES IN DEVELOPING COUNTRIES. PRODUCT QUALITY COMPLIANCE LABORATORIES IN THAILAND AND THE US ASSURE THE QUALITY OF CONTRACEPTIVES AND OTHER HEALTH PRODUCTS USED THROUGHOUT THE DEVELOPING WORLD, INCLUDING ANTIMALARIAL PRODUCTS AND ANTIRETROVIRAL DRUGS (0 NONE). 15071225 0 22805080 BIOLOGICAL & LIFE SCIENCES RESEARCH: FHI CONDUCTS CLINICAL AND EPIDEMIOLOGICAL RESEARCH, INCLUDING MULTINATIONAL RANDOMIZED CLINICAL TRIALS THAT EVALUATE DRUGS, DEVICES, AND PROCEDURES. FHI IS ADDRESSING BOTH LONG-STANDING AND EMERGING DISEASES IN THE DEVELOPING WORLD BY MANAGING CLINICAL TRIALS OF INEXPENSIVE MALARIA TREATMENTS, A ROTAVIRUS VACCINE, AND HIV PREVENTION TECHNOLOGIES INCLUDING TOPICAL MICROBICIDES. FHI PUBLISHES CLOSE TO 150 ARTICLES IN PEER-REVIEWED JOURNALS EACH YEAR ON ITS VAST ARRAY OF RESEARCH. (0 NONE) 0 0 0 301424502 1 0 0 0 0 0 0 0 0 1 1 0 0 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 193 0 1 661 1 0 1 BC BG BY CB CG CH DJ EG ET GH GV GY HA ID IN IV KE LA MA MI MZ NI NP PK PP RW SF SG SU TH TZ UG VM WA ZA ZI 0 0 0 0 0 0 0 8 2 0 1 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 NC X HUBERT C GRAVES 9195447040 2224 NC HWY 54 DURHAM NC 27713 DR ALBERT J SIEMENS 36 X X 357102 40780 35260 EDWARD W WHITEHORNE 2 X X 22473 34021 0 SUSAN DULL 2 X X 19272 0 0 MARTIN MITTAG-LENKHEYM LLD 2 X X 11970 0 0 DR TORREY C BROWN 2 X 22473 636 0 PETER W McCLEAN 2 X 17424 0 0 R P WOODSON III 1 X 8712 0 0 LUELLA KLEIN 1 X 3762 0 0 MARJORIE NEWMAN-WILLIAMS 40 X 0 0 0 ROBERT PRICE 40 X 253768 0 35713 HUBERT C GRAVES 40 X 362250 0 2966 DR WARD CATES 40 X 353099 0 34224 DR PETER LAMPTEY 40 X 339955 0 35161 SHEILA MITCHELL 40 X 271291 0 29910 MANISHA BHARTI 40 X 210312 0 31888 PAMELA MYERS 40 X 174783 0 28439 LAURA KAYSER 40 X 176665 0 28112 GARY WEST 40 X 220820 0 33367 MICHAEL WELSH 40 X 156583 0 23315 MARIE PORTER 40 X 95658 0 14141 DAVID MEIN 40 X 218003 0 26069 EDWARD DENNISON 40 X 160329 0 25982 DR TIM MASTRO 40 X 211204 0 23735 JOHN MCWILLIAM 40 X 243131 0 23564 CHRISTOPH HAMELMANN 40 X 243107 0 28545 ANTHONY BONDURANT 40 X 203417 0 23904 NZAPFURUNDI CHABIKULI 40 X 139349 0 17756 ROBERT MAGNANI 40 X 233582 0 23693 PETER COWLEY 40 X 280288 0 26222 TIM LOCKHARDT 40 X 259484 0 16575 BAKER NDUGGA MAGGWA 40 X 233581 0 24161 CATHERINE THOMPSON 40 X 226857 0 23947 CHARLES S SMOOT 40 X 267706 0 20403 5998410 75437 637052 133 1 1 0 NOVELLA CLINICAL INC 409 EMPEROR DURHAM NC 27703 CLIN. TRIALS DATA MGT 1075397 ERNST AND YOUNG LLP 4130 PARK LAKE RALEIGH NC 276122299 AUDITING 608690 TATUM LLC DEPT 952890 ATLANTA GA 311922890 MANAGEMENT SVCS. 362250 COVANCE LABORATORIES LTD 8211 SCICOR INDNPLS IN 46214 TESTING SERVICES 220895 AEROTEC SCIENTIFIC INC 3689 COLLECTION DR CHICAGO IL 60693 TEMPORARY STAFFING 207876 15 0 0 0 1351096 0 25265 0 1376361 PUBLIC HEALTH RSH USG 541700 294796728 294796728 0 0 PUBLIC HEALTH RSH OTHER 541700 54354940 54354940 0 0 0 0 0 0 349151668 259653 0 0 259653 0 0 0 0 0 0 0 0 1245258 0 1341825 0 -96567 0 -96567 0 0 -96567 0 0 0 0 350691115 349151668 0 163086 0 0 0 0 0 0 0 0 5285511 1216717 4068794 0 0 0 0 0 46373282 27788555 18528821 55906 4458190 2623875 1830153 4162 5457713 3087716 2365304 4693 3170446 1783122 1384616 2708 0 0 0 0 198592 28478 169837 277 713441 204657 508784 0 0 0 0 0 0 0 0 0 11215287 8932862 2145616 136809 18140861 15834580 2299202 7079 4188076 2495658 1692054 364 16406155 11081932 5324223 23541152 20587899 2951300 1953 0 0 0 0 12698639 11972385 726254 0 0 0 0 0 0 0 0 0 873603 144400 728130 1073 0 0 0 0 SUB AWARD CONTRACT PAYMENTS 120109207 120108143 1064 0 FIELD OFFICE STAFF COMPENSATION 63746160 61059984 2686176 0 EQUIPMENT 7362143 7343819 18324 0 FIELD OFFICE ADVANCES 4193793 4193793 0 0 MISCELLANEOUS 1109396 935927 175336 -1867 0 0 0 0 349241647 301424502 47603988 213157 42061128 23905564 1668745 2033413 0 0 26113815 38079034 0 0 0 0 0 0 0 0 1978473 1961952 6615499 4372166 2671695 2243333 0 0 0 0 0 0 5906836 10100629 80400692 78323925 28249422 26464787 0 0 27234391 20986942 0 0 0 0 0 0 0 0 67832 62372 6241925 10753234 61793570 58267335 X 18607122 20056590 0 0 0 0 18607122 20056590 80400692 78323925 X 0 1 1 X 1 1 X 1005861 949962 1320935 1519707 1376361 6172826 238766508 260817807 367917169 325885842 349151668 1542538994 239772369 261767769 369238104 327405549 350528029 1548711820 1548711820 1457202 2093821 1697056 1477768 1504911 8230758 0 1457202 2093821 1697056 1477768 1504911 8230758 241229571 263861590 370935160 328883317 352032940 1556942578 0.99471 0.9944 0.00529 0.0056 X 0 0 0 0 0 0 0 0 1715424 1555460 159964 0 2103683 1292090 811593 0 2796392 1524616 1271776 2243333 ADVANCED TO FIELD OFFICES 10100629 10100629 0 LIABILITY FOR ADVANCE TO FIELD OFFICES 10100629 DEFERRED RENT 652605 10753234 350691115 349241647 1449468 0 0 0 0 0 0 1449468 350691115 0 0 0 0 0 350691115 0 0 0 350691115 349241647 0 0 0 0 0 349241647 0 0 0 349241647 SchD_P10_S00_L00 Schedule D, Part X FHI'S FUNDERS PROVIDE ADVANCES TO FHI'S FIELD OFFICES WHICH ARE RECORDED AS EXPENSES. THE TOTAL AT 9/30/10 EQUALLED $10,100,629. FHI RENTS OFFICE SPACE THAT WITHIN THE LEASE PROVIDES FOR SEVERAL MONTHS OF NO RENT PAYMENTS DURING THE LIFE OF THE LEASE. PER GAAP, THESE NON CASH EXPENDITURE MONTHS ARE TO BE EXPENSED EQUALLY OVER THE LIFE OF THE LEASE WITH DEBITS TO EXPENSE AND CREDITS TO DEFERRED RENT.LINE 2 FIN 48-FHI ADOPTED THE PROVISIONS OF FIN 48 EFFECTIVE OCTOBER 1, 2009 AND THE ADOPTION OF THIS GUIDANCE DID NOT HAVE A MATERIAL IMPACT ON THE ACCOMPANYING FINANCIAL STATEMENTS. Sub-Saharan Africa 92 1590 Program Services Conducts research, program management and business development activities as directed by US Headquarters 132784458 East Asia and the Pacific 20 303 Program Services Conducts research, program management and business development activities as directed by US Headquarters 21569052 South Asia 16 185 Program Services Conducts research, program management and business development activities as directed by US Headquarters 17629711 Central America and the Caribbean 3 61 Program Services Conducts research, program management and business development activities as directed by US Headquarters 1885518 Middle East and North Africa 1 8 Program Services Conducts research, program management and business development activities as directed by US Headquarters 457695 South America 0 0 Program Services Research conducted under contract 1887750 132 2147 176214184 X 1 1 X X X 1 0 0 0 0 0 0 0 0 DR ALBERT J SIEMENS 357102 40780 0 0 0 0 28889 0 6371 0 392362 40780 0 0 EDWARD W WHITEHORNE 22473 34021 0 0 0 0 0 0 0 0 22473 34021 0 0 R P WOODSON III 8712 0 0 0 0 0 0 0 0 0 8712 0 0 0 MARTIN MITTAG-LENKHEYM LLD 11970 0 0 0 0 0 0 0 0 0 11970 0 0 0 PETER W McCLEAN 17424 0 0 0 0 0 0 0 0 0 17424 0 0 0 SUSAN DULL 19272 0 0 0 0 0 0 0 0 0 19272 0 0 0 DR TORREY C BROWN 22473 636 0 0 0 0 0 0 0 0 22473 636 0 0 LUELLA KLEIN 3762 0 0 0 0 0 0 0 0 0 3762 0 0 0 MARJORIE NEWMAN-WILLIAMS 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ROBERT PRICE 253768 0 0 0 0 0 29400 0 6313 0 289481 0 0 0 HUBERT C GRAVES 362250 0 0 0 0 0 0 0 2966 0 365216 0 0 0 DR WARD CATES 353099 0 0 0 0 0 29400 0 4824 0 387323 0 0 0 DR PETER LAMPTEY 339955 0 0 0 0 0 29400 0 5761 0 375116 0 0 0 SHEILA MITCHELL 271291 0 0 0 0 0 29400 0 510 0 301201 0 0 0 MANISHA BHARTI 210312 0 0 0 0 0 25622 0 6266 0 242200 0 0 0 PAMELA MYERS 174783 0 0 0 0 0 22222 0 6217 0 203222 0 0 0 LAURA KAYSER 176665 0 0 0 0 0 21895 0 6217 0 204777 0 0 0 MICHAEL WELSH 156583 0 0 0 0 0 17140 0 6175 0 179898 0 0 0 GARY WEST 220820 0 0 0 0 0 27094 0 6273 0 254187 0 0 0 MARIE PORTER 95658 0 0 0 0 0 11402 0 2739 0 109799 0 0 0 DAVID MEIN 218003 0 0 0 0 0 25600 0 469 0 244072 0 0 0 EDWARD DENNISON 160329 0 0 0 0 0 19800 0 6182 0 186311 0 0 0 DR TIM MASTRO 211204 0 0 0 0 0 23270 0 465 0 234939 0 0 0 CHARLES S SMOOT 267706 0 0 0 0 0 20403 0 0 0 288109 0 0 0 CHRISTOPH HAMELMANN 253107 0 0 0 0 0 21730 0 6815 0 281652 0 0 0 JOHN MCWILLIAM 243131 0 0 0 0 0 18191 0 5373 0 266695 0 0 0 ANTHONY BONDURANT 203417 0 0 0 0 0 18532 0 5372 0 227321 0 0 0 ROBERT MAGNANI 233582 0 0 0 0 0 19773 0 3920 0 257275 0 0 0 PETER COWLEY 280288 0 0 0 0 0 19407 0 6815 0 306510 0 0 0 TIM LOCKHARDT 259484 0 0 0 0 0 12713 0 3862 0 276059 0 0 BAKER NDUGGA MAGGWA 233581 0 0 0 0 0 18000 0 6161 0 257742 0 0 CATHERINE THOMPSON 226857 0 0 0 0 0 17132 0 6815 0 250804 0 0 NZAPFURUNDI CHABIKULI 139349 0 0 0 0 0 11342 0 6414 0 157105 0 0 0 SchJ_P01_S00_L01a Schedule J, Part I, Line 1a EMPLOYEES THAT ARE EMPLOYED OUTSIDE OF THE UNITED STATES HAVE LOCAL HOUSING COSTS PAID BY FHI. SchJ_P01_S00_L03 Schedule J, Part I, Line 3 FHI'S AUDIT COMMITTEE OF THE BOARD OF DIRECTORS SERVES AS THE COMPENSATION COMMITTEE AND SETS THE CEO'S COMPENSATION BASED ON PERFORMANCE REVIEW AND COMPARABILITY DATA FOR BOTH NOT-FOR-PROFIT AND FOR PROFIT ORGANIZATIONS. FURTHER DETAILS OF THE COMMITTEE'S ACTIVITIES ARE RECORDED AS FHI'S RESPONSE TO PART VI LINE 15B. SchJ_P01_S00_L04 Schedule J, Part I, Line 4 CHARLES S SMOOT RESIGNED IN AUGUST OF 2009 AND WAS PAID SEVERANCE AND CONSULTING FEES OF 153,040 DURING THE YEAR ENDED SEPTEMBER 30, 2010. F990_P06_S0A_L03 Form 990, Part VI, Section A, Line 3 CFO PRIOR TO SEPTEMBER 1, 2010 WAS AN EMPLOYEE OF A COMPANY THAT PROVIDES FINANCIAL MANAGEMENT STAFFING. F990_P06_S0B_L11 Form 990, Part VI, Section B, Line 11 FORM 990 IS COMPLETED BY FHI'S FINANCE, ACCOUNTING, AND LEGAL TEAM IN CONSULTATION WITH ERNST & YOUNG LLP. A FINAL REVIEW IS PERFORMED BY THE CFO, GENERAL COUNSEL, AND CEO. THE 990 IS THEN REVIEWED BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS WITH COPIES PROVIDED TO ALL BOARD MEMBERS. AFTER APROVAL HAS BEEN OBTAINED, THE 990 IS SUBMITTED TO THE IRS. F990_P06_S0B_L12c Form 990, Part VI, Section B, Line 12c FHI POLICY 020, "CONFLICTS OF INTEREST', ADOPTED BY BOARD RESOLUTION IS APPLICABLE TO EACH BOARD MEMBER AS WELL AS EACH EMPLOYEE. A DISCLOSURE FORM IS COMPLETED BY EACH BOARD MEMBER AT THEIR TIME OF APPOINTMENT AND BY EVERY EMPLOYEE AT THE INITIATION OF THEIR EMPLOYMENT. STATEMENTS COMPLETED BY BOARD MEMBERS ARE FILED WITH THE BOARD CHAIR. STATEMENTS BY U.S. BASED EMPLOYEES ARE FILED WITH THE HUMAN RESOURCES DEPARTMENT. STATEMENTS BY NON U.S. BASED EMPLOYEES ARE FILED WITH THE RELATED COUNTRY DIRECTOR AND HR OFFICE. THE POLICY REQUIRES DISCLOSURE ON AN ONGOING BASIS OF ANY CONFLICTS AS THEY ARISE. ADDITIONALLY, IN JULY OF EACH YEAR, FHI'S ASSISTANT CORPORATE SECRETARY OBTAINS A DISCLOSURE STATEMENT FROM EACH BOARD MEMBER FOR FILING WITH THE BOARD CHAIR AND FROM ALL EMPLOYEES AT THE LEVEL OF DIRECTOR AND ABOVE WHICH IS FILED WITH THE CEO. FHI'S CODE OF ETHICS AND CONDUCT, WHICH REFERENCES AND SUMMARIZES THE CONFLICTS OF INTEREST POLICY AND OTHER EXPECTATIONS REGARDING CONDUCT AND ETHICAL STANDARDS, IS PROVIDED TO EACH BOARD MEMBER UPON APPOINTMENT AND TO EACH EMPLOYEE UPON EMPLOYMENT. EACH SIGNS A STATEMENT THAT THEY HAVE REVIEWED THE FHI CODE OF CONDUCT. F990_P06_S0B_L15 Form 990, Part VI, Section B, Line 15 BOTH THE FHI BYLAWS IN ESTABLISHING THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS, AND THE CHARTER OF THE AUDIT COMMITTEE, PROVIDE THAT THE AUDIT COMMITTEE SHALL SERVE AS THE CORPORATE COMPENSATION COMMITTEE TO ESTABLISH THE COMPENSATION OF THE CORPORATION'S PRINCIPAL OFFICERS. THE AUDIT COMMITTEE, SERVING IN THIS CAPACITY, CONSTITUTES A COMMITTEE THAT IS INDEPENDENT OF THE COMPENSATED OFFICERS. ON AN ANNUAL BASIS, THE COMMITTEE OBTAINS COMPARABILITY DATA FOR THE POSITIONS REFLECTING A SAMPLE OF BOTH NOT-FOR-PROFIT AND COMMERCIAL ORGANIZATIONS, AND AN EXTERNAL SURVEY OF DATA SUCH AS THE RADFORD LIFE SCIENCES SURVEY, WHICH PROVIDES COMPENSATION AND PRACTICES DATA FOR 650 MULTINATIONAL LIFE SCIENCES COMPANIES. ADDITIONALLY, FOR EACH POSITION (EXCEPT FOR THAT OF THE CEO), THE COMMITTEE OBTAINS THE CEO'S RECOMMENDATIONS FOR OFFICER COMPENSATION LEVELS FOR THE COMING YEAR. THE COMMITTEE MEETS IN EXECUTIVE SESSION (INITIALLY WITH THE CEO) TO REVIEW THE CEO'S RECOMMENDATIONS AND ASSESSMENTS OF INDIVIDUAL PERFORMANCES DURING THE PRIOR YEAR. THEN, WITHOUT THE PRESENCE OF THE CEO, THE COMMITTEE MEETS TO (1) CONSIDER THE CEO'S PERFORMANCE DURING THE PRIOR YEAR;(2)CONSIDER THE CEO'S ASSESSMENT OF CORPORATE OFFICER PERFORMANCE AND RELATED RECOMMENDATIONS; (3) REVIEW THE RELEVANT COMPARABILITY DATA; (4) ESTABLISH OFFICER COMPENSATION LEVELS FOR THE COMING YEAR; AND (5) DOCUMENT THE COMMITTEE'S DELIBERATIONS AND DECISIONS. F990_P06_S0C_L19 Form 990, Part VI, Section C, Line 19 FHI'S ORGANIZATIONAL CHARTER IS AVAILABLE THROUGH THE WEBSITE OF THE NORTH CAROLINA SECRETARY OF STATE. FHI'S FORM 990, AUDITED FINANCIAL STATEMENTS AND CONFLICTS OF INTEREST POLICY ARE MADE AVAILABLE UPON REQUEST. F990_P07_S0A_L01a Form 990, Part VII, Section A, Line 1a MARJORIE NEWMAN-WILLIAMS HIRED AFTER DECEMBER 31, 2009 THEREFORE NO 2009 W-2 COMPENSATION TO REPORT. HUBERT GRAVES WAS HIRED SEPTEMBER 1, 2010. HIS SERVICES PRIOR TO THAT TIME WERE PAID TO A MANAGEMENT SERVICES PROVIDER. THAT VALUE IS SHOWN IN PART VII SECTION A. CHRISTOPH HAMELMANN AND NZAPFURUNDI CHABIKULI ARE NOT U.S. CITIZENS AND ARE EMPLOYED OUTSIDE OF THE UNITED STATES AND THEREFORE THEY DO NOT RECEIVE W-2 FORMS. DR SIEMENS IS EMPLOYED AN AVERAGE OF 4 HOURS PER WEEK BY NOVELLA AND MR. WHITEHORNE AVERAGES 3 HOURS PER WEEK BETWEEN NOVELLA AND THE FOUNDATION. SchR_P05_S00_L01c Schedule R, Part V, Line 1c FAMILY HEALTH INTERNATIONAL FOUNDATION CONTRIBUTION TO SUPPORT RESEARCH SchR_P05_S00_L01k Schedule R, Part V, Line 1k NOVELLA CLINICAL RESEARCH SERVICES SchR_P05_S00_L01l Schedule R, Part V, Line 1l NOVELLA CLINICAL PAYMENT FOR RESEARCH SERVICES SchR_P05_S00_L01p Schedule R, Part V, Line 1p FAMILY HEALTH INTERNATIONAL FOUNDATION REIMBURSEMENT FOR BOARD MEETING EXPENSES FAMILY HEALTH INTERNATIONAL FOUNDATION PO BOX 13950 RESEARCH TRIANGLE PARK NC 27709 561719871 PROVIDE SUPPORT FUNDS TO FHI NC 509A3 I N/A NOVELLA CLINICAL SUITE 400 EMPEROR BLVD DURHAM NC 27703 562095062 CLINICAL TRIALS DE FHI FDN C 0 0 0 0 0 1 0 0 0 0 0 0 0 1 1 0 0 0 1 0 0 FAMILY HEALTH INTERNATIONAL FOUNDATION c 1474000 NOVELLA CLINICAL k 60989 NOVELLA CLINICAL l 1014408 FAMILY HEALTH INTERNATIONAL FOUNDATION p 87747 EXTENSION APPLICATION WAS COMPLETED ON A TIMELY BASIS